HCP (HCP) - FREE Research Report

Anderson Scott A who is SVP and CAO at HCP INC sold 908 shares at $44.95 per share for a total value of $40,814.60 on July 1, 2013. Following this transaction, the SVP and CAO owned 22,980 shares meaning that the stake was reduced by 3.8% with the 908 share sell-off.

Mercer James W who is EVP,Gen Counsel and Corp Sec at HCP INC sold 2,538 shares at $44.95 per share for a total value of $114,083.10 on July 1, 2013. Following this transaction, the EVP,Gen Counsel and Corp Sec owned 31,013 shares meaning that the stake was reduced by 7.56% with the 2,538 share sell-off.

The shares most recently traded at $43.73, down $1.20, or 2.67% since the insider transactions. Historical insider transactions for HCP go as follows:

  • 4-Week # shares sold: 2,224
  • 12-Week # shares sold: 15,727
  • 24-Week # shares sold: 52,927

The average volume for HCP has been 3.1 million shares per day over the past 30 days. HCP has a market cap of $20.9 billion and is part of the financial sector and real estate industry. Shares are up 1.86% year to date as of the close of trading on Wednesday.

HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. The stock currently has a dividend yield of 4.57%. The company has a P/E ratio of 24.0. Currently there are 3 analysts that rate HCP a buy, 2 analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCP - FREE

TheStreet Quant Ratings rates HCP as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full HCP Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Ingredion (INGR) Reaches New Lifetime High Today

Ingredion (INGR) Hits New Lifetime High

New Lifetime High Today: Ingredion (INGR)

Today Ingredion (INGR) Hits New Lifetime High

New Lifetime High Reached By Ingredion (INGR)